Your browser doesn't support javascript.
loading
Effect of amino acid-based formula added to four-food elimination in adult eosinophilic esophagitis patients: A randomized clinical trial.
de Rooij, Willemijn E; Vlieg-Boerstra, Berber; Warners, Marijn J; Van Ampting, Marleen T J; van Esch, Betty C A M; Eussen, Simone R B M; Bredenoord, Albert J.
Afiliação
  • de Rooij WE; Department of Gastroenterology & Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Vlieg-Boerstra B; Department of Paediatrics, OLVG, Amsterdam, The Netherlands.
  • Warners MJ; Department of Nutrition & Dietetics, Hanze University of Applied Sciences, Groningen, The Netherlands.
  • Van Ampting MTJ; Department of Gastroenterology & Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • van Esch BCAM; Department of Gastroenterology and Hepatology, University Medical Center Utrecht and St. Antonius Hospital Nieuwegein, Amsterdam, The Netherlands.
  • Eussen SRBM; Danone Nutricia Research, Utrecht, The Netherlands.
  • Bredenoord AJ; Danone Nutricia Research, Utrecht, The Netherlands.
Neurogastroenterol Motil ; 34(7): e14291, 2022 07.
Article em En | MEDLINE | ID: mdl-34792264
ABSTRACT

BACKGROUND:

Elimination of key foods restricts dietary options in eosinophilic esophagitis (EoE) patients. Addition of amino acid-based formula (AAF) to an elimination diet might facilitate adherence and, therefore, enhance efficacy of dietary management.

AIM:

To evaluate whether addition of AAF to a four-food elimination diet (FFED) is more effective than FFED alone in decreasing eosinophilia, endoscopic signs, and clinical outcomes.

METHODS:

This randomized controlled trial enrolled 41 adult patients with active EoE (≥15 eosinophils (eos) per high power field (hpf)) at baseline biopsy. Subjects were randomized (11 ratio) to groups given a FFED or FFED with addition of AAF providing 30% of their daily energy needs (FFED + AAF). Histological disease activity, endoscopic signs, symptoms, and disease-related quality of life (EoEQoL) were measured at baseline and after 6 weeks of intervention.

RESULTS:

Patients (60% male, age 34.5 (interquartile range (IQR) 29-42.8 years)) were randomized to FFED (n = 20) or FFED + AAF (n = 21); 40 participants completed the diet. Complete histological remission (<15 eos/hpf) was achieved in 48% of FFED + AAF subjects (n = 21) vs. 25% of FFED subjects (n = 20), respectively (p = 0.204). Peak eosinophil counts (PEC) decreased significantly in both groups between baseline and week 6, but the change in PEC between groups was not different (p = 0.130). A significant but similar endoscopic and symptomatic reduction was observed in both groups (all; p<0.05). Total EoEQoL scores significantly improved in the FFED + AAF group between baseline and week 6 (p = 0.007), and not in the FFED group.

CONCLUSION:

The addition of AAF to a FFED did not lead to a larger decrease in PEC between baseline and 6 weeks, but may result in a significant improvement of QoL in adult EoE patients NL6014 (NTR6778).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esofagite Eosinofílica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esofagite Eosinofílica Idioma: En Ano de publicação: 2022 Tipo de documento: Article